A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin

Journal of Clinical Oncology

Volumn 9, Issue 4, 1991, Pages 606-613

  Fukuoka, Masahiro ^a   Masuda, Noriyuki ^b   Furuse, Kiyoyuki ^b   Negoro, Shunichi ^b   Takada, Minoru ^b   Matsui, Kaoru ^b   Takifuji, Nobuhide ^b   Kudoh, Shinzoh ^b   Kawahara, Masaaki ^b   Ogawara, Mitsumasa ^b   Kodama, Nagahisa ^b   Kubota, Kaoru ^b   Yamamoto, Masunari ^b   Kusunoki, Yoko ^b  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; MITOMYCIN; VINDESINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; MITOMYCINS; PROPORTIONAL HAZARDS MODELS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; VINDESINE;

EID: 0026081636     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.4.606     Document Type: Article

References (20)

1. Gralla RJ, Casper ES, Kelsen DP, et al: Cisplatin and vindesine combination for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern Med 95:414-420, 1981
2. Kris MG, Gralla RJ, Wertheim MS, et al: Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. Cancer Treat Rep 70:1091-1096, 1986
3. Kubota K, Nakai R, Ogawara M, et al: A randomized study of cisplatin (DDP) versus DDP plus vindesine (VDS) in advanced non-small cell lung cancer (NSCLC), with an analysis of prognostic factors using multivariate methods. Lung Cancer 4:A125, 1988 (abstr, suppl)
4. Takifuji N, Fukuoka M, Negoro S, et al: A phase II study in combination of cisplatin (P), vindesine (V) and mitomycin c (m) for non-small cell lung cancer (NSCLC). Lung Cancer 4:A132, 1988 (abstr, suppl)
5. Longeval E, Klastersky J: Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma: A study by the EORTC Lung Cancer Working Party (Belgium). Cancer 50:2751-2756, 1982
6. Kris MG, Gralla RJ, Kelsen DP, et al: Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment. Chest 87:368-372, 1985
7. Goldie JH, Coldman AJ, Gudanskas GA: Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66:439-449, 1982
8. Miller TP, Chen TT: Alternating combination chemotherapy prolongs survival for metastatic non-small cell lung cancer (NSCLC) (for The Southwest Oncology Group). Proc Am Soc Clin Oncol 2:188, 1983 (abstr)
9. Mountain CF: A new international staging system for lung cancer. Chest 89:225S-233S, 1986
10. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
12. Gehan E A: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203-223, 1965
13. SUGI Supplemented Library User's Guide, Version 5 Edition, SAS Institute Inc, 1986
14. Cox DR: Regression model and life tables. J R Stat Soc 34:187-220, 1972
15. Elliott JA, Ahmedzai S, Hole D, et al: Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study. Eur J Cancer Clin Oncol 20:1025-1032, 1984
16. Dhingra HM, Valdivieso M, Carr DT, et al: Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer. J Clin Oncol 3:176-183, 1985
17. Kris MG, Gralla RJ, Kalman LA, et al: Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment. Cancer Treat Rep 69:387-395, 1985
18. Carmichael J, Gregor A, Cornbleet MA, et al: Cisplatinum and vindesine in combination in the treatment of non-small cell lung cancer. Eur J Cancer Clin Oncol 21:811-814, 1985
19. Sinkai T, Saijo N, Tominaga K, et al: Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer. Cancer Treat Rep 69:945-951, 1985
20. Ruckdeschel JC, Finkelstein DM, Ettinger DS, et al: A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. J Clin Oncol 4:14-22, 1986